Purpose: To measure the computed tomography (CT) attenuation of acute pulmonary embolism (PE) and establish an upper Hounsfield unit (HU) threshold above which it is unlikely to occur. Materials and Methods: This retrospective study analyzed CT pulmonary angiography (CTPA) exams in patients with acute PE (2018–2023) who had a prior negative CTPA in the preceding 2 weeks. Clot and artifact attenuation were measured on the positive and prior negative CTPA respectively. Analysis of variance with post hoc tests and linear regression analysis were performed to determine the effects of technical and other parameters on clot and artifact attenuation. Results: A total of 60 patients were included, each with 1 record or a pair of CTPA exams, yielding 105 clots and 41 artifacts. Mean attenuation for acute PE was 50±40 HU, and for artifact was 110±146 HU. A threshold of 125 HU achieved 97% (102/105) sensitivity for acute PE below it and the same specificity for artifact above it. Specificity for acute PE below this threshold was 37% (15/41). Subsegmental clots had a lower attenuation than all other clots as a group. Kilovoltage peak (kVp) and proximal vessel attenuation were poor predictors of clot attenuation . Conclusions: Most acute PE demonstrated a CT attenuation ≤125 HU on standard CTPA, an upper threshold higher than previously reported, while artifacts demonstrated both lower and higher attenuation. An attenuation >125 HU on standard CTPA, favoring artifact rather than acute PE, may be a useful adjunct to morphologic differentiation between these entities.
A 10-Year Comprehensive, Single-Center, Retrospective Analysis on Juxtapleural Nodules: Insights into Classification and Risk
Background/Objectives: Juxtapleural and perifissural nodules are commonly encountered on thoracic imaging, are typically presumed benign, and are often considered to represent intrapulmonary lymph nodes. We evaluated the prevalence, clinical context, and management of juxtapleural nodules over a 10-year period and to assess factors associated with concern for malignancy. Methods: In this retrospective, single-center study, radiology reports from 1 January 2015 to 31 December 2024, were queried using natural language processing to identify examinations containing terminology consistent with juxtapleural nodules. After exclusion of duplicate encounters, 85,435 unique patient encounters were analyzed. Reports were further filtered to identify cases with imaging concern for malignancy and recommendations for follow-up or intervention (N = 659). Clinical characteristics, imaging modality, and prior malignancy history were compared using appropriate statistical tests. Results: Among 85,435 unique encounters, 659 patients (<1%) had juxtapleural nodules considered concerning for malignancy. These patients were older (68 vs. 64 years, p < 0.001), more frequently imaged with PET/CT (8% vs. 5%, p < 0.001), and more likely to be evaluated in inpatient settings (16% vs. 12%, p < 0.001). Of the cohort with a juxtapleural nodule considered concerning for malignancy by imaging criteria, 360 patients (55%) had a prior history of malignancy. In these patients, nodules were more commonly identified in outpatient settings (70% vs. 43%, p < 0.001) and on routine imaging (94% vs. 86%, p < 0.001). Representative cases demonstrated that malignant nodules may mimic benign perifissural morphology on initial imaging. Conclusions: Although the vast majority of reported juxtapleural nodules did not prompt malignancy-directed evaluation, a small subset of cases (approximately 0.8%), particularly in patients with prior malignancy, were interpreted as sufficiently concerning to warrant follow-up imaging or intervention. Because pathologic confirmation and standardized long-term outcome adjudication were not available for all patients, these findings should be interpreted as reflecting real-world radiologist concern and management patterns rather than a definitive malignancy rate.